Latest Tri Locum Partners LP Stock Portfolio

$813Million | No. of Holdings #19

Tri Locum Partners LP Performance

2026 Q2+7.73%

YTD+11.09%

2025+17.81%

About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $813.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Tri Locum Partners LP are JNJ, VRTX, LLY. The fund has invested 13.3% of it's portfolio in JOHNSON & JOHNSON and 12.3% of portfolio in VERTEX PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off THERMO FISHER SCIENTIFIC INC (TMO), ASCENDIS PHARMA A/S (ASND) and NUVALENT INC (NUVL) stocks. They significantly reduced their stock positions in INTUITIVE SURGICAL INC (ISRG), DEFINIUM THERAPEUTICS INC and MADRIGAL PHARMACEUTICALS INC (MDGL). Tri Locum Partners LP opened new stock positions in ASCENDIS PHARMA A/S, REVOLUTION MEDICINES INC (RVMD) and CYTOKINETICS INC (CYTK). The fund showed a lot of confidence in some stocks as they added substantially to AXSOME THERAPEUTICS INC. (AXSM), VERTEX PHARMACEUTICALS INC (VRTX) and JAZZ PHARMACEUTICALS PLC (JAZZ).

Tri Locum Partners LP Equity Portfolio Value

Last Reported on: 14 Aug, 2026

$813Million

as of Aug 14, 2026

Tri Locum Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Tri Locum Partners LP made a return of 7.73% in the last quarter. In trailing 12 months, it's portfolio return was 35.76%.

Performance
S&P 500

New Buys

Ticker	$ Bought
ascendis pharma a/s	69,011,100
enliven therapeutics inc	43,985,800
revolution medicines inc	28,433,200
cytokinetics inc	16,526,900
beta bionics inc	7,730,700

New stocks bought by Tri Locum Partners LP

Additions

Ticker	% Inc.
axsome therapeutics inc.	253
vertex pharmaceuticals inc	56.05
jazz pharmaceuticals plc	39.74
argenx se	31.49
tarsus pharmaceuticals inc	29.99
eli lilly & co	23.85
dexcom inc	17.52
johnson & johnson	2.52

Additions to existing portfolio by Tri Locum Partners LP

Reductions

Ticker	% Reduced
intuitive surgical inc	-68.69
definium therapeutics inc	-55.9
madrigal pharmaceuticals inc	-33.9
united therapeutics corp del	-33.17
teva pharmaceutical inds ltd	-26.85
dianthus therapeutics inc	-17.06

Tri Locum Partners LP reduced stake in above stock

Sold off

Ticker	$ Sold
nuvalent inc	-31,606,400
ascendis pharma a/s	-58,402,100
thermo fisher scientific inc	-65,085,000

Tri Locum Partners LP got rid off the above stocks

Sector Distribution

Tri Locum Partners LP has about 78% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	78
Others	22

Market Cap. Distribution

Tri Locum Partners LP has about 73.5% of it's portfolio invested in the large-cap and mega-cap stocks.

LARGE-CAP
MEGA-CAP
UNALLOCATED
MID-CAP

Category	%
LARGE-CAP	48.9
MEGA-CAP	24.6
UNALLOCATED	22
MID-CAP	4.6

Stocks belong to which Index?

About 65.2% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.

S&P 500
Others
RUSSELL 2000

Index	%
S&P 500	46
Others	34.8
RUSSELL 2000	19.2

Top 5 Winners (%)		%
	definium therapeutics inc	107.3 %
LLY	eli lilly & co	26.7 %
AXSM	axsome therapeutics inc.	24.8 %
ARGX	argenx se	23.1 %
JAZZ	jazz pharmaceuticals plc	22.7 %

Top 5 Winners ($)		$
LLY	eli lilly & co	19.3 M
AXSM	axsome therapeutics inc.	10.7 M
JAZZ	jazz pharmaceuticals plc	9.9 M
VRTX	vertex pharmaceuticals inc	8.3 M
	definium therapeutics inc	7.5 M

Top 5 Losers (%)		%
TARS	tarsus pharmaceuticals inc	-9.2 %
ISRG	intuitive surgical inc	-9.0 %
UTHR	united therapeutics corp del	-7.2 %

Top 5 Losers ($)		$
ISRG	intuitive surgical inc	-6.4 M
UTHR	united therapeutics corp del	-3.0 M
TARS	tarsus pharmaceuticals inc	-2.1 M

Tri Locum Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Tri Locum Partners LP

Tri Locum Partners LP has 19 stocks in it's portfolio. About 80% of the portfolio is in top 10 stocks. ISRG proved to be the most loss making stock for the portfolio. LLY was the most profitable stock for Tri Locum Partners LP last quarter.

$813.22MTotal Value

22.00Positions

14 Aug, 2026Last Reported

Current holdings of Current Stock Holdings of Tri Locum Partners LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ARGX Argenx Se Argenx Se ARGX Tri Locum Partners LP's holding in Argenx Se over time	4.74%	41,596	$38.59M 4.74%	increased 31.49 percentadded

ASND Ascendis Pharma A/S Ascendis Pharma A/S ASND Tri Locum Partners LP's holding in Ascendis Pharma A/S over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

AXSM Axsome Therapeutics Inc. Axsome Therapeutics Inc.AXSM Tri Locum Partners LP's holding in Axsome Therapeutics Inc. over time	6.6%	219,308	$53.68M 6.6%	increased 253.06 percentadded

CYTK Cytokinetics Inc Cytokinetics IncCYTK Tri Locum Partners LP's holding in Cytokinetics Inc over time	2.03%	194,000	$16.53M 2.03%	new position

DXCM Dexcom Inc Dexcom IncDXCM Tri Locum Partners LP's holding in Dexcom Inc over time	6.8%	820,479	$55.26M 6.8%	increased 17.52 percentadded

ISRG Intuitive Surgical Inc Intuitive Surgical IncISRG Tri Locum Partners LP's holding in Intuitive Surgical Inc over time	2.35%	47,983	$19.08M 2.35%	decreased 68.69 percentreduced

JAZZ Jazz Pharmaceuticals Plc Jazz Pharmaceuticals PlcJAZZ Tri Locum Partners LP's holding in Jazz Pharmaceuticals Plc over time	6.57%	221,720	$53.43M 6.57%	increased 39.74 percentadded

JNJ Johnson & Johnson Johnson & JohnsonJNJ Tri Locum Partners LP's holding in Johnson & Johnson over time	13.27%	424,945	$107.92M 13.27%	increased 2.52 percentadded

LLY Eli Lilly & Co Eli Lilly & CoLLY Tri Locum Partners LP's holding in Eli Lilly & Co over time	11.29%	76,532	$91.79M 11.29%	increased 23.85 percentadded

MDGL Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals IncMDGL Tri Locum Partners LP's holding in Madrigal Pharmaceuticals Inc over time	4.51%	68,273	$36.66M 4.51%	decreased 33.9 percentreduced

NUVL Nuvalent Inc Nuvalent IncNUVL Tri Locum Partners LP's holding in Nuvalent Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

RVMD Revolution Medicines Inc Revolution Medicines IncRVMD Tri Locum Partners LP's holding in Revolution Medicines Inc over time	3.5%	151,822	$28.43M 3.5%	new position

TARS Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals IncTARS Tri Locum Partners LP's holding in Tarsus Pharmaceuticals Inc over time	2.54%	328,340	$20.67M 2.54%	increased 29.99 percentadded

TEVA Teva Pharmaceutical Inds Ltd Teva Pharmaceutical Inds LtdTEVA Tri Locum Partners LP's holding in Teva Pharmaceutical Inds Ltd over time	3.11%	746,835	$25.30M 3.11%	decreased 26.85 percentreduced

TMO Thermo Fisher Scientific Inc Thermo Fisher Scientific IncTMO Tri Locum Partners LP's holding in Thermo Fisher Scientific Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

UTHR United Therapeutics Corp Del United Therapeutics Corp DelUTHR Tri Locum Partners LP's holding in United Therapeutics Corp Del over time	3.13%	47,026	$25.48M 3.13%	decreased 33.17 percentreduced

VRTX Vertex Pharmaceuticals Inc Vertex Pharmaceuticals IncVRTX Tri Locum Partners LP's holding in Vertex Pharmaceuticals Inc over time	12.33%	201,791	$100.24M 12.33%	increased 56.05 percentadded

Ord Shs Ascendis Pharma A/S Ascendis Pharma A/S Tri Locum Partners LP's holding in Ascendis Pharma A/S over time	8.49%	258,740	$69.01M 8.49%	new position

Com Enliven Therapeutics Inc Enliven Therapeutics Inc Tri Locum Partners LP's holding in Enliven Therapeutics Inc over time	5.41%	866,716	$43.99M 5.41%	new position

Com Dianthus Therapeutics Inc Dianthus Therapeutics Inc Tri Locum Partners LP's holding in Dianthus Therapeutics Inc over time	1.45%	120,712	$11.77M 1.45%	decreased 17.06 percentreduced